The Concept Foundation is finalizing the first part of a project with the goal to increase the availability and accessibility of quality-assured, affordable combi-packs of medical abortion pills to all women who seek a safe medical abortion. So far, the groundwork has been laid for work in two regions: Central Asia and Southern Africa. The momentum has led to a second phase of funding to support the longer-term initiatives for increased access to these critical medicines. One of the goals of this project is to work towards pooled-procurement of safe medical abortion combi-packs, to allow smaller countries and regions to place orders together in order to benefit from the lowest possible price of this quality assured product. They are working with a few manufacturers of quality-assured combi-packs. They have produced several documents to help with these efforts, among others on the cost structure of mife-miso combi-packs, the quality assurance of the products, and a complete roadmap for introducing products in countries.
Concept Foundation continues to support efforts to increase access to Medabon®, the only quality-assured mifepristone–misoprostol combi-pack currently available in LMICs at an affordable price. UNFPA proposes the combipack at the lowest possible price. [Each pack contains one mifepristone 200 mg tablet to be taken orally and four 200 mcg misoprostol tablets to be used 24-48 hours later – either sub-lingually or vaginally]. The combi-pack is currently registered in more than 15 countries. The Foundation continues to engage with partners and to support registration and introduction in more countries in need. Their progress continues to show that it is possible to increase access to affordable, quality-assured reproductive health products that improve and save women’s lives.
SOURCE: Conception Foundation E-mail, 28 March 2019